L-Leucine, N-formyl-,(3S,4S,6S)-3-hexyltetrahydro-2-oxo-6-undecyl-2H-pyran-4-yl ester (9CI) (130676-65-2)

Identification
Name:	L-Leucine, N-formyl-,(3S,4S,6S)-3-hexyltetrahydro-2-oxo-6-undecyl-2H-pyran-4-yl ester (9CI)
Synonyms:	L-Leucine,N-formyl-, 3-hexyltetrahydro-2-oxo-6-undecyl-2H-pyran-4-yl ester, [3S-(3a,4a,6b)]-; Ro 40-4441
CAS:	130676-65-2
Molecular Formula:	C29H53 N O5
Molecular Weight:	498.7533
InChI:	InChI=1/C29H53NO5/c1-5-7-9-11-12-13-14-15-16-18-24-21-27(25(28(32)34-24)19-17-10-8-6-2)35-29(33)26(30-22-31)20-23(3)4/h22-27H,5-21H2,1-4H3,(H,30,31)/i3D3
Molecular Structure:
Properties
Flash Point:	336.408°C
Boiling Point:	632.638°C at 760 mmHg
Density:	1.002g/cm³
Refractive index:	1.482
Flash Point:	336.408°C
Safety Data

Other Product

Orlistat Related Compound D (10 mg) (N-formyl-L-leucine (3S,4R,6S)-tetrahydro-3-hexyl-2-oxo-6-undecyl-2H-pyran-4-yl ester)
2H-Pyran-2-one,3-hexyltetrahydro-4-hydroxy-6-undecyl-, (3S,4S,6R)-
2H-Pyran-2-one, 3-hexyltetrahydro-4-hydroxy-6-undecyl-
(3S,4S,6S)-3-Hexyl-3,4,5,6-tetrahydro-4-hydroxy-6-undecyl-2H-pyran-2-one
2H-Pyran-2-one,tetrahydro-4-hydroxy-3-methyl-6-(1-methylethyl)-,(3S,4S,6S)-(9CI)
(3S,4S,6R)-4-(benzyloxy)-3-hexyl-3,4,5,6-tetrahydro-6-undecyl-2H-pyran-2-one
L-Leucine, 3-formyl-N-(4-methoxyphenyl)-, ethyl ester, (3S)-
Carbamic acid,[(3S,6S)-6-(bromomethyl)tetrahydro-2-oxo-2H-pyran-3-yl]-,phenylmethyl ester
L-Leucine, N-formyl-,(1S)-1-[(2S,3S)-3-(butoxycarbonyl)-2-hydroxynonyl]dodecyl ester (9CI)
(2S,3S,4S,5R,6S)-6-(1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carbonyloxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid
Cyclopenta[c]pyran-4-carboxylicacid, 6-[[[(2S,3R,4S)-3-ethenyl-2-(b-D-glucopyranosyloxy)-3,4-dihydro-4-(2-hydroxyethyl)-2H-pyran-5-yl]carbonyl]oxy]octahydro-7-methyl-3-oxo-,methyl ester, (4S,4aS,6S,7R,7aS)- (9CI)
Cyclopenta[c]pyran-4-carboxylicacid, 6-[[[(2S,3R,4S)-3-ethenyl-2-(b-D-glucopyranosyloxy)-3,4-dihydro-4-(2-oxoethyl)-2H-pyran-5-yl]carbonyl]oxy]octahydro-7-methyl-1-oxo-,methyl ester, (4S,4aS,6S,7R,7aS)- (9CI)
2H-Pyran-3-carboxylicacid, 4-aminotetrahydro-6-methoxy-2-methyl-, methyl ester, (2R,3S,4S,6S)-rel-
2H-Pyran-2-one,6-[(1E,3S,4S,7E,10R)-4,10-dihydroxy-1,3,5,5,7-pentamethyl-6-oxo-1,7-pentadecadien-1-yl]-4-[[(1,1-dimethylethyl)diphenylsilyl]oxy]tetrahydro-,(4S,6S)-
L-Tyrosine,3-iodo-N-[[[[(4S,4aR,5S,6S)-4,4a,5,6-tetrahydro-6-methyl-4-[(2S)-2-methyl-1-oxobutoxy]-5-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-2(3H)-naphthalenylidene]amino]oxy]acetyl]-,methyl ester (9CI)
1-Naphthacenecarboxylicacid,2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7,10-tetrahydroxy-6,11-dioxo-4-[[2,3,4-trideoxy-4-O-[5-[(5,6-dihydro-6-methyl-5-oxo-2H-pyran-2-yl)oxy]tetrahydro-6-methyl-2H-pyran-2-yl]-3-(dimethylamino)-a-L-lyxo-hexopyranosyl]oxy]-,methyl ester, [2R-[2a(1R*,2R*,4S*),5b(2R*,6S*),6b]]-(9CI)
Cyclopenta[c]pyran-4-carboxylic acid,6-[[[(2S,3S,4S)-3-formyl-3,4-dihydro- 4-(2-methoxy-2-oxoethyl)-2-methyl-2Hpyran- 5-yl]carbonyl]oxy]-1,4a,5,6,7,7ahexahydro- 1-hydroxy-7-methyl-,methyl ester,(1R,4aS,6S,7R,7aS)-
Cyclopenta[c]pyran-4-carboxylicacid,6-[[[(2S,3S,4R,6S)-4-[(1E)-1-formyl-1-propenyl]tetrahydro-2-hydroxy-6-methoxy-2H-pyran-3-yl]carbonyl]oxy]-1-(b-D-glucopyranosyloxy)-1,4a,5,6,7,7a-hexahydro-7-methyl-,methyl ester, (1S,4aS,6S,7R,7aS)- (9CI)
1-Naphthacenecarboxylicacid,4-[[(2R,5S,6S)-5-[[2,6-dideoxy-4-O-[(2R,6S)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-a-L-lyxo-hexopyranosyl]oxy]tetrahydro-6-methyl-2H-pyran-2-yl]oxy]-2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7,10-tetrahydroxy-6,11-dioxo-,methyl ester, (1R,2R,4S)- (9CI)
2H-Pyran-2-heptanoic acid, 6-hexyltetrahydro-, methyl ester